Within the B-SCREEN platform, Chafik Hamdad leverages his expertise in life sciences, biotechnology and biological data analysis to contribute to the identification of B cells and therapeutic antibodies from patient samples. Marseille, June 25, 2026 – Chafik Hamdad has spent several years in biotechnology R&D, developing expertise in next-generation sequencing, cellular and molecular biology, immuno-oncology and […]
An Innovative Cell Therapy for Triple-Negative Breast Cancer
During this National Breast Cancer Awareness Month, dedicated to raising awareness of breast cancer, a promising breakthrough has emerged at the CRCM – Marseille Cancer Research Center. Marseille, November 23, 2025 – Under the leadership of Prof. Daniel Olive and Dr. Marc Lopez, a team of researchers has developed a new generation of CAR-T cells […]
ImmunoSkills: €3 Million to train the immunotherapy experts of tomorrow
The ‘Campus des Métiers et des Qualifications d’Excellence’ announced on Tuesday, September 29, 2025, that the French government will provide €3 million in funding to train the next generation of immunotherapy specialists. Marseille, September 23, 2025 – The ImmunoSkills project, developed in partnership with the Marseille Immunology Biocluster (MIB), has been selected as a laureate […]
A French-American breakthrough rewrites DNA to defeat cancer
A 36-year-old American patient with stage IV colorectal cancer was facing a critical situation: all conventional treatments had failed. Today, however, she has been in complete remission for nearly two years thanks to her participation in a groundbreaking clinical trial conducted at the prestigious Masonic Cancer Center at the University of Minnesota in Minneapolis. This […]
MIB is supported by a Scientific Advisory Board of Excellence
The Marseille Immunology Biocluster (MIB) is now guided by an International Scientific Advisory Board (SAB), composed of globally recognized scientists known for their expertise and integrity. A shared expertise guiding innovation As an independent body, the SAB ensures the scientific rigor, innovation, and high standards at the core of MIB’s research projects. Chaired by Professor […]
MIB in Shanghai: The strategic role of Clinical Investigation Centers in the evolution of global healthcare
Lors du DIA China Annual Meeting 2025 à Shanghai, le Dr Daniel Olive (Professeur d’immunologie, praticien hospitalier et responsable médical, scientifique et technique de MIB) a participé à la table ronde d’ouverture aux côtés de représentants de Chine, d’Arabie Saoudite et des États-Unis. Together, they explored the role of clinical investigation centers in the […]
The MIB raises the voice of immunology at the heart of Europe
Last week in Brussels, the Marseille Immunology Biocluster (MIB) took a major step forward by asserting its presence on the European stage. During a conference dedicated to Europe’s role in life sciences, Denis Bertin, co-founder of the MIB, delivered a powerful message emphasizing the urgency of repositioning immunology as a central pillar of contemporary biomedical […]
Advancing Europe’s leadership in life science
Innovation in immunology at the heart of the European agenda On June 12, 2025, in Brussels, patient representatives, public decision-makers, industry leaders, researchers, and European representatives will come together within the European Committee of the Regions to discuss sovereignty and competitiveness drivers in healthcare. This high-level European conference, jointly organized by the Marseille Immunology Biocluster […]
Skin Summit 2025: Vitiligo, a Gateway to a New Era in Applied Immunology
On April 24 and 25, 2025, Eurobiomed – a founding member of MIB – organized the Skin Summit in Antibes, an event that brought together international dermatology experts for two days of rich scientific exchange. This first edition was a great success, driven by inspiring talks and thought-provoking discussions. Vitiligo, a complex autoimmune disease, was […]
MIB: Press kit November 8, 2024
Marseille Immunology Biocluster: working for tomorrow’s immunology for the benefit of patients. EDITOR’S NOTE from Eric Berton,President of Aix Marseille University,Chairman of the A*Midex Foundation With the birth of the Marseille Immunology Biocluster (MIB), a revolution in immunotherapy is now underway in France. MIB is not just a place where advances in immunopharmacology are imagined, […]